BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18263595)

  • 1. Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T/T genotype at 1580 C/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease.
    Sumita Y; Sugiura T; Kawaguchi Y; Baba S; Soejima M; Murakawa Y; Hara M; Kamatani N
    Rheumatology (Oxford); 2008 Mar; 47(3):289-91. PubMed ID: 18263595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
    Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
    Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
    Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCRBV20S1 and TCRBV3S1 gene segment polymorphisms in systemic sclerosis.
    Bredemeier M; Chies JA; Wieck A; Capobianco KG; Pitrez EH; Rohde LE; Pinotti AF; Brenol JC; Xavier RM
    J Rheumatol; 2008 Jun; 35(6):1058-63. PubMed ID: 18412309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population.
    Almasi S; Erfani N; Mojtahedi Z; Rajaee A; Ghaderi A
    Genes Immun; 2006 Jul; 7(5):401-6. PubMed ID: 16775619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
    Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease.
    Odani T; Yasuda S; Ota Y; Fujieda Y; Kon Y; Horita T; Kawaguchi Y; Atsumi T; Yamanaka H; Koike T
    Rheumatology (Oxford); 2012 Oct; 51(10):1765-74. PubMed ID: 22723597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis.
    Sugiura Y; Banno S; Matsumoto Y; Niimi T; Yoshinouchi T; Hayami Y; Naniwa T; Ueda R
    J Rheumatol; 2003 Jul; 30(7):1520-3. PubMed ID: 12858451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
    Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
    Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers.
    Ewis AA; Kondo K; Dang F; Nakahori Y; Shinohara Y; Ishikawa M; Baba Y
    Am J Ind Med; 2006 May; 49(5):367-73. PubMed ID: 16570259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein deficiency in familial interstitial lung disease.
    Amin RS; Wert SE; Baughman RP; Tomashefski JF; Nogee LM; Brody AS; Hull WM; Whitsett JA
    J Pediatr; 2001 Jul; 139(1):85-92. PubMed ID: 11445799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
    Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis.
    Lee EB; Zhao J; Kim JY; Xiong M; Song YW
    Arthritis Rheum; 2007 Jul; 56(7):2443-8. PubMed ID: 17599774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common mutation in the surfactant protein C gene associated with lung disease.
    Cameron HS; Somaschini M; Carrera P; Hamvas A; Whitsett JA; Wert SE; Deutsch G; Nogee LM
    J Pediatr; 2005 Mar; 146(3):370-5. PubMed ID: 15756222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology.
    Beretta L; Bertolotti F; Cappiello F; Barili M; Masciocchi M; Toussoun K; Caronni M; Scorza R
    Hum Immunol; 2007 Jul; 68(7):603-9. PubMed ID: 17584583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L; Cappiello F; Barili M; Scorza R
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
    Jack DL; Cole J; Naylor SC; Borrow R; Kaczmarski EB; Klein NJ; Read RC
    Clin Infect Dis; 2006 Dec; 43(11):1426-33. PubMed ID: 17083016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.